← Back to Search

Other

Caloric Restriction Diet for Sarcoma

N/A
Recruiting
Led By Santiago A Lozano-Calderón, MD, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >18 years
Biopsy proven soft tissue sarcoma located in the lower extremities
Must not have
Other cancers diagnosed within the last 5 years (in situ and/or invasive)
Diabetes mellitus
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 3 months and 6 months visits after surgery
Awards & highlights
No Placebo-Only Group

Summary

This trial is exploring if reducing calories before surgery can reduce wound complications after surgery.

Who is the study for?
This trial is for adults over 18 with a confirmed soft tissue sarcoma in the lower extremities, who are not pregnant or breastfeeding, don't have diabetes or other cancers within the last 5 years, and aren't on metformin therapy. They must have normal organ function and blood counts, a BMI ≥ 20 kg/m2, and be scheduled for radiation followed by surgery.
What is being tested?
The study tests if eating fewer calories can reduce surgical wound complications in sarcoma patients undergoing pre-operative radiation therapy. Participants will follow a caloric restriction diet before their tumor surgery to see if it helps improve outcomes.
What are the potential side effects?
Potential side effects of the caloric restriction diet may include fatigue due to lower energy intake, possible nutritional deficiencies if not monitored properly, and potential exacerbation of any pre-existing conditions related to food intake.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
My biopsy confirmed I have soft tissue sarcoma in my legs.
Select...
I can care for myself but may need occasional help.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not been diagnosed with any other cancer in the last 5 years.
Select...
I have diabetes.
Select...
I am currently taking metformin.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 3 months and 6 months visits after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks, 3 months and 6 months visits after surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change In The Rate Of Physical Function By MSTS
Change In The Rate Of Physical Function By TESS

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Caloric Restriction DietExperimental Treatment1 Intervention
Patients will meet with the Registered Dietitian to discuss calorie, protein, and fluid needs.The dietitian will calculate calorie needs. * Calorie needs will be reduced by 30%. * Protein needs will be estimated based on 0.8g/kg BW and then reduced by 70%. * Dietitian will educate participants on electrolytes and fluid intake based on the reduced food intake.
Group II: Normal DietActive Control1 Intervention
Participant will follow a normal diet.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,026 Previous Clinical Trials
13,413,788 Total Patients Enrolled
NORCH (Nutrition Obesity Research Center at Harvard)UNKNOWN
1 Previous Clinical Trials
30 Total Patients Enrolled
Santiago A Lozano-Calderón, MD, PhDPrincipal InvestigatorMassachusetts General Hospital
Karen De Amorin Bernstein, MDPrincipal InvestigatorMassachusetts General Hospital
~1 spots leftby May 2025